With recent advances in cancer detection and prevention, a future where cancer can be cured is starting to feel within reach. One significant area of progress is early detection, which can go a long way toward eliminating cancer. Most early detection methods, such as mammograms and colonoscopies, are unpleasant and, in some cases, invasive. Alternative, minimally invasive methods are needed to improve patient compliance and improve early detection rates.
Access this whitepaper to discover a next-generation sequencing-based assay that:- Can detect cancer from a single blood sample
- Has a higher sensitivity than the current gold-standard test
- Targets DNA methylation sequences
